Close

Professor Ambrose Agweyu

Professor of Infectious Disease Epidemiology

United Kingdom

Affiliations

Department of Infectious Disease Epidemiology and International Health
Faculty of Epidemiology and Population Health

Selected Publications

Countries should strengthen their health information systems.
Strong, K; Abajobir, A; Aboud, F; AGWEYU, A; Billah, SM; Black, M; Brinkman, S; Cerna-Turoff, I; Dandona, R; Ekman, C; Horiuchi, S; Huicho, L; JAMALUDDINE, Z; LAZZERINI, M; Maiga, A; Munos, M; Weigel, R;
2025
BMJ (Clinical research ed.)
Rethinking the evidence on COVID-19 in Africa.
Bejon, P; AGWEYU, A; Ochola-Oyier, LI; Hamaluba, M; Kamuya, D; Kinyanjui, S; Barasa, E;
2025
The Lancet. Infectious diseases
Pilot implementation of short message service for randomisation in a multisite pragmatic factorial clinical trial in Kenya.
Chepkirui, M; Kimego, D; Nzioki, C; Jowi, E; OPONDO, C; AGWEYU, A;
2025
Pilot and feasibility studies
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration
Kagucia, EW; VOLLER, S; Ziraba, AK; Bigogo, G; Munywoki, PK; Makobu, K; Nokes, DJ; Nyagwange, J; Orlendo, C; Akech, D; Sigilai, A; Onyango, C; Juma, B; Herman-Roloff, A; Munyua, P; Apondi, C; Lidechi, S; Audi, A; Ouma, A; Aol, G; Misore, T; Nasimiyu, C; Onyango, D; Lo, T; Kasera, K; ... Scott, JA G.
2025
Gates Open Research
Active vaccine safety surveillance: Experience from a prospective cohort event monitoring study of COVID-19 vaccines in Kenya
Odhiambo, DB; Akech, D; Karia, B; Kimani, M; Sang, S; Sigilai, A; VOLLER, S; Mataza, C; Mang’ong’o, D; Jalang’o, R; Mandale, M; Etyang, AO; Scott, JA G; AGWEYU, A; Kagucia, EW;
2025
Cold Spring Harbor Laboratory
Replication Data for: Active vaccine safety surveillance in sub-Saharan Africa: Experience from a prospective cohort event monitoring study of COVID-19 vaccines in Kenya
Odhiambo, DB; Akech, D; Karia, B; Kimani, M; Sang, S; Sigilai, A; VOLLER, S; Mataza, C; Mang’ong’o, D; Jalang’o, R; Mandale, M; Etyang, AO; SCOTT, JA G; AGWEYU, A; Kagucia, EW;
2025
Havard Dataverse
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.
Lugano, D; Kutima, B; Kimani, M; Sigilai, A; Gitonga, J; Karani, A; Akech, D; Karia, B; Ziraba, AK; Maina, A; Lambisia, A; Omuoyo, D; Mugo, D; Lucinde, R; Owuor, S; Konyino, G; Newman, J; Bailey, D; Nduati, E; Githinji, G; Agoti, CN; Bejon, P; SCOTT, JA G; AGWEYU, A; Kagucia, W; ... Nyagwange, J.
2024
BMC infectious diseases
See more information